Campylobacter Jejuni Challenge Model Development: Dose Ranging Study

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Campylobacter Infections
Interventions
BIOLOGICAL

Campylobacter jejuni strains CG8421 and BH-01-0142

Campylobacter jejuni strains CG8421 and BH-01-0142 at a single dose. Dosing will be based on attack rate, to achieve a 75% attack rate. Anticipate use of 10\^6-10\^9 CFU

Trial Locations (1)

05405

University of Vermont College of Medicine, Burlington

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

collaborator

TD Vaccines A/S

INDUSTRY

lead

University of Vermont

OTHER

NCT00434798 - Campylobacter Jejuni Challenge Model Development: Dose Ranging Study | Biotech Hunter | Biotech Hunter